2011 annual financial data
Enanta Pharmaceuticals 2011 Net income growth
Direct answer
Net income growth was 194.91%.
Operating income was 25,299,000 USD and net income was 23,310,000 USD.
Operating cash flow was 24,019,000 USD.
Get free Enanta Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 41,882,000 USD
- Operating income
- 25,299,000 USD
- Net income
- 23,310,000 USD
- Operating cash flow
- 24,019,000 USD